ADIPOQ and Obesity: The anti-inflammatory and athero-protective adiponectin, which also improves insulin sensitivity, was found to be low in obesity and coronary artery disease (CAD), while leptin, an immunomodulatory and IR promoter that is elevated in obesity, was strongly correlated with obesity and independently with CAC [102].